Guangping Gao - Sio Gene Chief Advisor
SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Insider
Guangping Gao is Chief Advisor of Sio Gene Therapies
Phone | 877 746 4891 |
Web | https://www.siogtx.com |
Sio Gene Management Efficiency
The company has return on total asset (ROA) of (0.2434) % which means that it has lost $0.2434 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.475) %, meaning that it created substantial loss on money invested by shareholders. Sio Gene's management efficiency ratios could be used to measure how well Sio Gene manages its routine affairs as well as how well it operates its assets and liabilities.Sio Gene Therapies currently holds 2.36 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Sio Gene Therapies has a current ratio of 6.33, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Sio Gene's use of debt, we should always consider it together with its cash and equity.
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York. Sio Gene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. Sio Gene Therapies (SIOX) is traded on NASDAQ Exchange in USA and employs 12 people. Management Performance
Return On Equity | -0.47 | |||
Return On Asset | -0.24 |
Sio Gene Therapies Management Team
Elected by the shareholders, the Sio Gene's board of directors comprises two types of representatives: Sio Gene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sio. The board's role is to monitor Sio Gene's management team and ensure that shareholders' interests are well served. Sio Gene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sio Gene's outside directors are responsible for providing unbiased perspectives on the board's policies.
Raquel Crystal, Head Operations | ||
David JD, CFO, CEO | ||
Guangping Gao, Chief Advisor |
Sio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sio Gene a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.47 | |||
Return On Asset | -0.24 | |||
Current Valuation | (23.36 M) | |||
Shares Outstanding | 73.98 M | |||
Shares Owned By Insiders | 25.30 % | |||
Shares Owned By Institutions | 26.82 % | |||
Number Of Shares Shorted | 71.39 K | |||
Price To Book | 0.54 X | |||
EBITDA | (70.94 M) | |||
Net Income | (71.89 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |